Skip to main content
Kevan Herold, MD, Endocrinology, New Haven, CT, Yale-New Haven Hospital

KevanCliffordHeroldMD

Endocrinology • New Haven, CT

Diabetes, Lipid Metabolism

Professor, Immunobiology, Yale University School of Medicine

Join to view full profile

Dr. Herold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Herold's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1986
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1979 - 1982
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2025
  • CT State Medical License
    CT State Medical License 2006 - 2024
  • IL State Medical License
    IL State Medical License 1982 - 1999
  • PA State Medical License
    PA State Medical License 1981 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Call for Improved Reporting of Human Islet Characteristics in Research Articles  
    Steven E Kahn, Kevan C Herold, Maureen Gannon, Diabetologia
  • Identification and Analysis of Islet Antigen–Specific CD8+ T Cells with T Cell Libraries  
    Kevan C Herold, Andrea K Steck, The Journal of Immunology
  • Reprogramming Human T Cell Function and Specificity with Non-Viral Genome Targeting  
    Neil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature
  • Join now to see all

Lectures

  • Abnormal Neutrophil Signature in the Blood and Pancreas of Presymptomatic and Symptomatic Type 1 Diabetes 
    New Haven, CT - 6/15/2014

Press Mentions

  • 5 Medical Advances That Will Change Patient Care
    5 Medical Advances That Will Change Patient CareMay 4th, 2023
  • Are We Proof That a New Drug to Stop Diseases like Arthritis and Type 1 Diabetes Really DOES Work?
    Are We Proof That a New Drug to Stop Diseases like Arthritis and Type 1 Diabetes Really DOES Work?April 3rd, 2023
  • Delaying Type 1 Diabetes Progression: Major Trial Readouts to Watch in 2023
    Delaying Type 1 Diabetes Progression: Major Trial Readouts to Watch in 2023February 17th, 2023
  • Join now to see all

Grant Support

  • Human And Translational ImmunologyNational Institute Of Allergy And Infectious Diseases2010–2011
  • Type 1 Diabetes Trialnet: Clinical Center At Yale University (U01)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
  • Administrative Core A, Component Of Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
  • Innate And Adaptive Immune Responses In Pre-Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
  • Type 1 Diabetes Trialnet: Clinical Center At Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Safety And PK Of Hokt3yl (Ala-Ala) In TidmNational Center For Research Resources2005
  • Islet Transplants With Renal AllograftsNational Center For Research Resources2005
  • Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Combination Of Anti-Cd3 And Ag-Specific ImmunotherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Phase II Multiple Dose Treatment Of Type 1 Diabetes Mellitus With Hokt3gammalNational Center For Research Resources2004–2005
  • Hokt3yl(Ala-Ala) In New Onset Type 1 Diabetes MellitusNational Center For Research Resources2004–2005
  • Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
  • Phase I/II Trial Of Hokt3(1(Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Hokt3yl (Ala Ala) In New Onset Type I Diabetes MellitusNational Center For Research Resources2000–2002
  • T Cell Activation And Repertoire In Insulin Dependent Diabetes / Anti CD40L TrialNational Institute Of Allergy And Infectious Diseases1999–2002
  • Type 1 Diabetes Trialnet:Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2001
  • Clinical Research Training In Immunosuppression And DiabNational Center For Research Resources2000
  • Diabetes Prevention Trial--Type I DiabetesNational Center For Research Resources1996–1997
  • Immunoregulation Of IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1995
  • Islet Cell Reactive T-Lymphocytes In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Immune Mechanism For Preventing Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • Islet Cell Reactive T Lymphocytes In Murine DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1993

Professional Memberships

Hospital Affiliations

Dr. Kevan Herold, Dr. Kevan Herold, MD, Dr. K Herold, Dr. Kevan Clifford Herold